By comparing C57 mice with two dyslipidemic models, LDL-receptor null (LDLR-/-) and LCAT/LDL-receptor null mice (LCAT-/-xLDLR-/-), our lab showed an observation of ER-membrane cholesterol being necessary to modulate ER-stress in a high-cholesterol-diet feeding paradigm. Here, we hypothesized that hepatic cholesterol biosynthesis plays an important role in mediating high-fat-diet-induced hepatic ER stress and NAFLD. In vivo, we fed C57, LDLR-/-, LCAT-/-xLDLR-/- mice a high-fat-diet for 16 weeks. Markers for hepatic ER-stress, cholesterol biosynthesis, ER-cholesterol, NAFLD and inflammasome were measured. High-fat-diet feeding induced ER-stress, NAFLD, cholesterol biosynthesis, NLRP3 activation and ER-membrane cholesterol accumulation in both...
Non-alcoholic steatohepatitis (NASH) involves steatosis combined with inflammation, which can progre...
Background & Aims: Non-alcoholic steatohepatitis (NASH) involves steatosis combined with inflammatio...
Mitochondrial dysfunction and endoplasmic reticulum (ER) stress have been implicated in hepatic stea...
By comparing C57 mice with two dyslipidemic models, LDL-receptor null (LDLR-/-) and LCAT/LDL-recepto...
Our laboratory has recently reported that lecithin:cholesterol acyltransferase (LCAT) deficient mice...
Non-alcoholic fatty liver disease (NAFLD) is highly prevalent. 20-30% of patients with NAFLD progres...
Nonalcoholic steatohepatitis (NASH) involves liver lipid accumulation (steatosis) combined with hepa...
The oxysterol-activated nuclear receptor liver X receptor alpha (LXRalpha) has been implicated in th...
The pathogenesis of nonalcoholic steatohepatitis (NASH), like that of atherosclerosis, involves lipi...
Background & Aims: Type 2 diabetes and nonalcoholic steatohepatitis (NASH) are associated with insul...
International audienceThis study explores the mechanisms responsible for the fatty liver setup in mi...
Hepatic inflammation is the key factor in non-alcoholic steatohepatitis (NASH) and promotes progress...
Hepatic inflammation is the key factor in non-alcoholic steatohepatitis (NASH) and promotes progress...
BACKGROUND & AIMS: Non-alcoholic steatohepatitis (NASH) involves steatosis combined with inflamm...
Non-alcoholic steatohepatitis (NASH) involves steatosis combined with inflammation, which can progre...
Background & Aims: Non-alcoholic steatohepatitis (NASH) involves steatosis combined with inflammatio...
Mitochondrial dysfunction and endoplasmic reticulum (ER) stress have been implicated in hepatic stea...
By comparing C57 mice with two dyslipidemic models, LDL-receptor null (LDLR-/-) and LCAT/LDL-recepto...
Our laboratory has recently reported that lecithin:cholesterol acyltransferase (LCAT) deficient mice...
Non-alcoholic fatty liver disease (NAFLD) is highly prevalent. 20-30% of patients with NAFLD progres...
Nonalcoholic steatohepatitis (NASH) involves liver lipid accumulation (steatosis) combined with hepa...
The oxysterol-activated nuclear receptor liver X receptor alpha (LXRalpha) has been implicated in th...
The pathogenesis of nonalcoholic steatohepatitis (NASH), like that of atherosclerosis, involves lipi...
Background & Aims: Type 2 diabetes and nonalcoholic steatohepatitis (NASH) are associated with insul...
International audienceThis study explores the mechanisms responsible for the fatty liver setup in mi...
Hepatic inflammation is the key factor in non-alcoholic steatohepatitis (NASH) and promotes progress...
Hepatic inflammation is the key factor in non-alcoholic steatohepatitis (NASH) and promotes progress...
BACKGROUND & AIMS: Non-alcoholic steatohepatitis (NASH) involves steatosis combined with inflamm...
Non-alcoholic steatohepatitis (NASH) involves steatosis combined with inflammation, which can progre...
Background & Aims: Non-alcoholic steatohepatitis (NASH) involves steatosis combined with inflammatio...
Mitochondrial dysfunction and endoplasmic reticulum (ER) stress have been implicated in hepatic stea...